Blueprint Investment Partners LLC Zoetis Inc. Transaction History

Blueprint Investment Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$151.44 - $200.09 $5,603 - $7,403	-37 Reduced 2.92%	1,231 $242,000
Q3 2023 Nov 15, 2023	SELL	$167.14 - $192.77 $24,736 - $28,529	-148 Reduced 10.45%	1,268 $220,000
Q2 2023 Aug 15, 2023	SELL	$160.94 - $186.23 $199,243 - $230,552	-1,238 Reduced 46.65%	1,416 $243,000
Q1 2023 May 12, 2023	BUY	$145.48 - $175.02 $386,103 - $464,503	2,654 New	2,654 $441,000
Q1 2022 May 16, 2022	SELL	$181.39 - $234.03 $278,252 - $359,002	-1,534 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$193.69 - $247.03 $52,877 - $67,439	273 Added 21.65%	1,534 $374,000
Q3 2021 Nov 04, 2021	BUY	$189.29 - $209.69 $238,694 - $264,419	1,261 New	1,261 $245,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Blueprint Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Blueprint Investment Partners LLC with notifications on news.